Table 2. Correlation between BTN2A2 and CFs of patients.

Clinicopathological features	Total (N)	Odds ratio (OR)	P-value
WHO grade (G3&G4 vs. G2)	635	7.634 (5.263–11.236)	<0.001
IDH status (Mut vs. WT)	686	0.076 (0.050–0.113)	<0.001
1p/19q codeletion (non-codel vs. codel)	689	8.276 (5.371–13.180)	<0.001
Primary therapy outcome (SD vs. PD)	259	0.460 (0.277–0.759)	0.003
Age (>60 vs. ≤60)	696	3.848 (2.568–5.882)	<0.001
Histological type (Glioblastoma vs. Astrocytoma)	363	11.562 (6.348–22.658)	<0.001